According to this, just out on ZeroHedge, that’s what’s happened.
As we’ll see below, there’s certainly something unprecedented going on, specifically in biotech.
The prior update made the argument, biotech SPBIO, has a unique distinction that’s showing up on the leveraged inverse fund LABD, shorting the sector.
For illustration purposes, we’re going to do a little ‘trick’.
The weekly close of SPBIO, is shown below.
This index does not provide volume but we’re going to ‘fix’ that by putting in the lower panel, weekly volume for leveraged inverse fund LABD.
It’s clear, as SPBIO reached all-time highs and reversed, short activity via LABD picked up significantly.
However, the past several weeks tells us from a Wyckoff perspective, something major could be about to happen.
As SPBIO, has moved counter-trend higher, activity going short (via LABD) has gone off the scale.
If the unprecedented volume activity weren’t enough to draw attention, we also have a repeating set-up that’s well, repeating; Spring-to-Up-Thrust.
With the idea originally obtained from the late Daivd Weis, later confirmed time and again, it’s a unique (high probability) characteristic of market behavior.
That’s where we are now.
SPBIO: Up Close & Technical
It may be hard to see in the above chart.
The next one, moves closer-in.
The upward advance of SPBIO slowed dramatically last week, closing up just +1.68%, for the week.
Contrast that move with the week prior at +13.83%, and the slowdown is evident.
All Hands, On Deck
Figuratively speaking, everything’s been dropped to focus exclusively on this sector. It’s obvious, what’s going on at this juncture is unprecedented.
That goes for the rest of the markets as well.
However, this sector alone, is telling us to ‘look here’; potentially setting up for a major reversal.
Charts by StockCharts
Note: Posts on this site are for education purposes only. They provide one firm’s insight on the markets. Not investment advice. See additional disclaimer here.
The Danger Point®, trade mark: No. 6,505,279